No Picture
Trading Ideas

In Global Electricity Slump, Coal Is the Big Loser

(Bloomberg) — As silent factories and deserted offices hobble demand for electricity worldwide, the biggest loser is coal.In the U.S., coal’s share of power generation has dropped more than 5 percentage points since February on the nation’s biggest grid while output from natural gas plants and wind farms held steady. In Europe, it’s down 2 points. Even in China and India, where coal still dominates, it’s losing market share during the pandemic.It comes down to cost. Coal power is more expensive than gas and renewables in many places and, hence, is the first fuel priced out of the market when …read more […]

No Picture
Trading Ideas

Boeing negotiation for Embraer's commercial division 'no longer helpful': CEO

Boeing, which is working to bring its 737 MAX jet back into service after two fatal crashes, canceled the $4.2 billion deal for the Brazilian company’s regional jet division over the weekend, prompting Embraer to initiate arbitration. “It is deeply disappointing, but we had reached a point where continued negotiation was no longer helpful,” Calhoun told the virtual meeting. Calhoun said Boeing expects it will take two to three years for travel to return to 2019 levels and an additional few years more for industry’s long-term trend growth to return. …read more […]

No Picture
Trading Ideas

2 5G Stocks to Consider as the Trend Heats Up

5G is here. The new digital wireless technology first started to make waves in 2017, with connectivity tests in Argentina, Norway, and Poland. By late 2018, active 5G networks were starting to appear on a limited basis in various urban areas, and in 2019 the first nationwide networks went into operation in the US and China. As 2020 matures, industry analysts expect to see these networks expand, as providers move into the mid- and high-frequency bands.The new network rollout brings with it a slew of opportunities, as does any new technology. Original equipment manufacturers will need new components. The new …read more […]

Healthcare

CytoDyn (OTC: CYDY) Announces Vyrologix as Proprietary Name for Leronlimab as a Combination Therapy for Highly Treatment Experienced HIV Patients in the United States

Company appoints Interim Chief Financial Officer VANCOUVER, Washington, Apr 27, 2020  — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for […]